Terns Pharmaceuticals, Inc. (TERN)

NASDAQ: TERN · Real-Time Price · USD

29.36

+2.23 (8.22%)

At close: Dec 5, 2025, 4:00 PM EST

29.11

-0.25 (-0.85%)

After-hours: Dec 5, 2025, 7:56 PM EST

Terns Pharmaceuticals Employees

Terns Pharmaceuticals had 59 employees as of December 31, 2024. The number of employees decreased by 7 or -10.61% compared to the previous year.

Employees

59

Change (1Y)

-7

Growth (1Y)

-10.61%

Revenue / Employee

n/a

Profits / Employee

-$1,600,593

Market Cap

2.64B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	59	-7	-10.61%
Dec 31, 2023	66	20	43.48%
Dec 31, 2022	46	5	12.20%
Dec 31, 2021	41	11	36.67%
Dec 31, 2020	30	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

TERN News

2 days ago - Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors - The Motley Fool
21 days ago - Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London - GlobeNewsWire
25 days ago - Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
4 weeks ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
4 weeks ago - Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades - Benzinga
4 weeks ago - Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting - GlobeNewsWire
6 weeks ago - Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data? - Benzinga
6 weeks ago - Terns Pharma ends obesity drug program after mid-stage trial data - Reuters